Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cerna

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomideWhoon Jong Kil, David Cerna, William E Burgan, et al.
Journal of Cardiovascular Pharmacology|June 7, 2012
Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effectsSanjeewani T Palayoor, Molykutty J-Aryankalayil, Adeola Y Makinde, et al.
Radiation Research|August 24, 2010
Fractionated radiation therapy can induce a molecular profile for therapeutic targetingMolykutty John-Aryankalayil, Sanjeewani T Palayoor, David Cerna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularineHideaki Dote, David Cerna, William E Burgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone)Christopher A Barker, William E Burgan, Donna J Carter, et al.
Translational Oncology|October 24, 2013
mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 StatusCharles B Simone, Molykutty John-Aryankalayil, Sanjeewani T Palayoor, et al.
Radiation Research|July 26, 2012
Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cellsMolykutty John-Aryankalayil, Sanjeewani T Palayoor, Adeola Y Makinde, et al.
Radiation Research|April 7, 2021
SMAC Mimetic/IAP Inhibitor Birinapant Enhances Radiosensitivity of Glioblastoma MultiformeDavid Cerna, Bora Lim, Yusuf Adelabu, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2009
Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]Andrew G Jobson, George T Lountos, Philip L Lorenzi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomideWhoon Jong Kil, David Cerna, William E Burgan, et al.
Journal of Cardiovascular Pharmacology|June 7, 2012
Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effectsSanjeewani T Palayoor, Molykutty J-Aryankalayil, Adeola Y Makinde, et al.
Radiation Research|August 24, 2010
Fractionated radiation therapy can induce a molecular profile for therapeutic targetingMolykutty John-Aryankalayil, Sanjeewani T Palayoor, David Cerna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularineHideaki Dote, David Cerna, William E Burgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone)Christopher A Barker, William E Burgan, Donna J Carter, et al.
Translational Oncology|October 24, 2013
mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 StatusCharles B Simone, Molykutty John-Aryankalayil, Sanjeewani T Palayoor, et al.
Radiation Research|July 26, 2012
Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cellsMolykutty John-Aryankalayil, Sanjeewani T Palayoor, Adeola Y Makinde, et al.
Radiation Research|April 7, 2021
SMAC Mimetic/IAP Inhibitor Birinapant Enhances Radiosensitivity of Glioblastoma MultiformeDavid Cerna, Bora Lim, Yusuf Adelabu, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2009
Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]Andrew G Jobson, George T Lountos, Philip L Lorenzi, et al.
Pageof 2